Article
Exploring the role of chemerin in skeletal muscle phenotype in those with kidney disease.
Translational research : the journal of laboratory and clinical medicine - 1 Apr 2026
Baker Luke A, Wilkinson Thomas J, Abbott Amelia Rmj, Cardoso Daniela F, Parker Nicola, Denniff Matthew J, Billany Roseanne E, March Daniel S, Young Hannah Ml, Highton Patrick, Graham-Brown Matthew Pm, Ashford Robert U, Viana João L, Burton James O, Smith Alice C, Watson Emma L
Abstract excerpt
INTRODUCTION: People with chronic kidney disease (CKD) often experience poor muscle quality and elevations in skeletal muscle wasting and dysfunction, contributing to a reduced quality of life and an increased risk of morbidity and mortality. The adipokine chemerin is associated with CKD progression and is involved in inflammatory-related signalling processes. With chronic inflammation recognised as a driving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
